Clinical Trial to Evaluate the Safety and Efficacy of EXG001-307 in Patients With Spinal Muscular Atrophy Type I
Clinical trial NCT06576388 · COMPLETED
Trial details
- NCT number
- NCT06576388
- Sponsor
- Guangzhou Jiayin Biotech Ltd
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-21
- Primary completion
- 2023-09-21
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.